Basic Overview
Pancragen is a pancreatic-targeting epigenetic regulatory tetrapeptide developed by the Khavinson team in Russia. Its amino acid sequence is Lys-Glu-Asp-Trp (KEDW), and its molecular weight is 576 Da. It belongs to the tissue-specific bioregulatory peptide category. The prototype is extracted from bovine pancreatic tissue and is a pure, artificially synthesized product. It targets both endocrine and exocrine repair of the pancreas and is only used as a laboratory research raw material. It has not yet received drug approval from major regulatory agencies such as the FDA, EMA, and NMPA.
Main Functions
Pancragen's core function focuses on the repair and metabolic regulation of the pancreas. The pancreas is responsible for producing digestive enzymes and hormones that regulate blood sugar (such as insulin). Pancragen can specifically act on pancreatic cells, restoring the function of intracellular insulin receptors. In addition, it can stimulate the pancreas's protective mechanisms, enhancing its resistance to toxic substances such as alcohol and drugs, and strengthening the comprehensive therapeutic effect against pancreatic-related diseases.
Core Advantages
Targeted Repair of Pancreatic Function: Pancragen acts precisely on the pancreas, improving digestive disorders, nutrient absorption problems, and abnormal insulin secretion caused by pancreatic dysfunction.
Prevention of Metabolic and Pancreatic Diseases: By regulating cellular function, Pancragen shows a positive effect in preventing pancreatitis and the development of diabetes, especially suitable for individuals with age-related glucose metabolism abnormalities (e.g., over 50 years old).
Enhancing Cellular Antitoxicity: It stimulates the pancreas's protective function, helping the organ resist long-term damage from external toxic substances (such as alcohol and drugs), thereby reducing the burden on the organ.
Disadvantages and Limitations
Strict Restrictions on Research Use: Currently, Pancragen products on the market are mainly defined as "pharmaceutical intermediates" or "laboratory scientific research" for use, and have not yet been widely approved for routine drug or health supplement use in personal clinical treatment.
Demanding Storage and Transportation Conditions: As a polypeptide, Pancragen has high requirements for storage environment, usually requiring low-temperature, vacuum packaging, which increases the difficulty of daily storage and logistics.
Limited Clinical Data and Popularity: Although studies have shown its positive regulatory effect on the pancreas, its long-term safety, efficacy in a broader population, and potential side effects still require further validation with larger-scale clinical data.
How to Order?
First, please inform us of your needs or application scenario.
Second, we will provide a quotation based on your needs or our suggestions.
Third, the customer confirms the sample and pays a deposit.
Fourth, we are responsible for arranging production. Discounts are available for bulk orders.
How is the quality of your products? First, our products are of excellent and stable quality. We conduct 100% testing before shipment.
Therefore, we conduct strict quality control before shipment. If any quality problems are found to be caused by us, we will replace the product free of charge or provide a refund.
How to Establish a Long-Term, Positive Partnership with Us?
1. We insist on providing high-quality products and competitive prices to ensure customer benefits;
2. We respect every customer, treat them as friends, and sincerely do business and make friends with them, no matter where they come from.
Hot Tags: purchase peptide drug pancragen 20mg/vial, China purchase peptide drug pancragen 20mg/vial manufacturers, suppliers, factory
